, ritonavir) or discontinuation of a cytochrome P450 3A4 inducer which include rifampin, carbamazepine, and phenytoin, might lead to a rise in codeine plasma concentrations with subsequently higher metabolism by cytochrome P450 2D6, resulting in bigger morphine amounts, which could raise or extend adverse reactions and will bring about potentially https://akorn-codeine79999.mdkblog.com/38039689/fascination-about-akorn-promethazine-codeine